Market Share of 3D Bioprinting Industry
The 3D bioprinting market is very competitive in nature. The market is concentrated due to the presence of various small and large players. Some of the significant players in the market are 3D Systems Corporation, Aspect Biosystems Ltd, GeSIM GmbH, Cellink AB, Cyfuse Biomedical KK, and Envision TEC GmbH.
- May 2024: Nanoscribe and Advanced BioMatrix collaborated to lead the way in the field of bioprinting by introducing four cutting-edge bioresins designed specifically for Two-Photon Polymerization (2PP) based 3D printing. This partnership brings together Nanoscribe's extensive knowledge in highly accurate 3D printing and Advanced BioMatrix's expertise in developing biomaterials, with the goal of greatly improving bioprinting capabilities. These groundbreaking bioresins offer unparalleled precision, resolution, and adaptability, opening up new avenues for exploration and advancement in the life sciences and biomedical sectors and ultimately contributing to the progress of human health.
- September 2023: CELLINK entered into a strategic distribution agreement with Paralab, which signified a notable growth in its operations in Portugal and Spain. This partnership was expected to enable CELLINK to reach a wider audience in Southern Europe by offering advanced bioprinting solutions. By doing so, the company reaffirmed its dedication to advancing regenerative medicine while taking into account the specific characteristics of the region. The collaboration will prioritize the exchange of knowledge, training, and technical support, ensuring that researchers in Portugal and Spain can effectively utilize CELLINK's state-of-the-art bioprinting platforms.
3D Bioprinting Market Leaders
-
Cellink
-
3D Systems Corporation
-
3D Bioprinting Solutions
-
REGEMAT 3D
-
Aspect Biosystems Ltd
*Disclaimer: Major Players sorted in no particular order
